A study of intravenous R744 in renal anemia patients on hemodialysis.
Phase 2
- Conditions
- Anemia
- Registration Number
- JPRN-jRCT2080220218
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adult patients >=20 years of age
Hemodialysis patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method